A two-site, open-label, non-randomized update, suggests focal electrically administered seizure therapy (FEAST) may have a reduced time to re-orientation compared to right unilateral ultra-brief pulse electroconvulsive therapy (UBP-RUL ECT)

G Sahlem,E Short,W Mccall,P Rosenquist,J Fox,A Manett,Z Nahas,C Mazingue,M George,H Sackeim

doi:10.1016/j.brs.2018.12.418

A two-site, open-label, non-randomized update, suggests focal electrically administered seizure therapy (FEAST) may have a reduced time to re-orientation compared to right unilateral ultra-brief pulse electroconvulsive therapy (UBP-RUL ECT)

G Sahlem, E Short + Show 8 more

https://doi.org/10.1016/j.brs.2018.12.418

Copy DOI

Journal: Brain Stimulation	Publication Date: Jan 22, 2019
Citations: 2

Affiliation: Medical University of South Carolina, Augusta University, University of Minnesota, Ralph H. Johnson VA Medical Center, Columbia University

#Focal Electrically Administered Seizure Therapy #Unilateral Ultra-Brief Pulse Electroconvulsive Therapy + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Background: Focal Electrically Administered Seizure Therapy (FEAST) is a form of ECT which maximally focuses the electrical stimulus to the frontal lobe. Recent open-label studies suggest that FEAST’s enhanced focality may lead to reduced cognitive side effects (1, 2), however there are no studies directly comparing FEAST to other forms of ECT (such as Right Unilateral Ultra-Brief Pulse Electroconvulsive therapy (UBP-RUL-ECT). We subsequently compared the efficacy, and cognitive side effect burden of FEAST and UBP-RUL-ECT.

Full Text